ERA-EDTA 2019 Epigenetics contribute to vascular calcification, which is a hallmark of CVD in CKD. Prof. Brandenburg explains how BET inhibition can interfere with factors and pathways associated with vascular calcification.
This lecture by prof. Vincent Brandenburg was part of a CME accredited symposium "Vascular calcification in kidney disease: Epigenetics as a novel approach?" held during ERA-EDTA 2019 in Budapest, Hungary.
Vincent Brandenburg , MD is head of the Division of Nephrology at the Rhein-Maas Klinikum in Würselen, Germany.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant from Resverlogix.The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
- Vascular calcification in kidney disease: Epigenetics as a novel approach?Epigenetic mechanisms targeting ALP: A pathway for prevention of vascular calcification?
Marta Ruiz-Ortega, PhD
- Vascular calcification in kidney disease: Epigenetics as a novel approach?The role of ALP as predictor of CV events and vascular calcification in CKD
Dr. Mathias Haarhaus, MD